Cognitive REmediation After Trauma Exposure Trial = CREATE Trial
Stopped The funding agency, DoD, determined that the study could not meet its enrollment numbers by the end of the grant.
Conditions
- Posttraumatic Stress Disorder
- Traumatic Brain Injury
Interventions
- DRUG: Methylphenidate Hydrochloride 20 mg
- DRUG: Placebo Capsule
- DRUG: Galantamine 12 mg
Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Collaborators